Ollin Biosciences, Inc. funding
Ollin Biosciences, Inc., a biotechnology company based in Austin, TX (founded 2022), filed a Form D with the SEC on June 24, 2026 and reported $156M raised of a $330M offering.
Amount raised$156M
Offering size$330M
Filed with the SECJune 24, 2026
First saleMay 14, 2026
IndustryBiotechnology
SecuritiesEquity
LocationAustin, TX
Founded2022
Entity typeCorporation
Investors so far32
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 24
Other health care rounds in Texas
OncoNano Medicine, Inc.$10.1M · Oct 8BiotechnologySolaris Endovascular Inc.$5M · Oct 1BiotechnologyTransformer TX Holdings, LLC$4.1M · Nov 9Hospitals and PhysiciansTeos Health, LLC$3.1M · Oct 30Other Health CareCerenome, Inc.$3M · Sep 18Other Health CareFibroBiologics, Inc.$1.2M · Oct 13PharmaceuticalsPressio, Inc.$544K · Oct 6Other Health CareIctero Medical, Inc.$344K · Nov 5Other Health Care